FDA Inspection 1194596 — Allergan Pharmaceuticals Ireland

Allergan Pharmaceuticals Ireland — FEI 3002806285

The FDA completed an inspection of Allergan Pharmaceuticals Ireland on June 17, 2022 in Westport. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 17, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Westport (Ireland)

Additional Details

Mutual Recognition Agreement (MRA)